Paige Aiello has joined The Barbara Ann Karmanos Cancer Institute as a breast surgeon and member of the Breast Cancer Multidisciplinary Team.
Phase III STELLAR clinical study results have demonstrated that the combination of eflornithine and lomustine achieved clinically meaningful improvements in overall survival and progression-free survival compared to lomustine alone in patients with recurrent IDH mutant, grade 3 astrocytoma.
